Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 348

1.

Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.

Gangaraju R, Chen Y, Hageman L, Wu J, Francisco L, Kung M, Ness E, Parman M, Weisdorf DJ, Forman SJ, Arora M, Armenian SH, Bhatia S.

Cancer. 2019 Aug 30. doi: 10.1002/cncr.32488. [Epub ahead of print]

PMID:
31469420
2.

Aichi Virus Induces Antiviral Host Defense in Primary Murine Intestinal Epithelial Cells.

Chang YT, Kung MH, Hsu TH, Hung WT, Chen YS, Yen LC, Chang TH.

Viruses. 2019 Aug 19;11(8). pii: E763. doi: 10.3390/v11080763.

3.

Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.

Wu J, Chen Y, Hageman L, Francisco L, Ness EC, Parman M, Kung M, Watson JA, Weisdorf DJ, Snyder DS, McGlave PB, Forman SJ, Arora M, Armenian SH, Bhatia R, Bhatia S.

Cancer. 2019 Nov 15;125(22):4033-4042. doi: 10.1002/cncr.32443. Epub 2019 Aug 14.

PMID:
31412155
4.

Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis.

Chu TH, Huang ST, Yang SF, Li CJ, Lin HW, Weng BC, Yang SM, Huang SC, Wu JC, Chang YC, Wen ZH, Chen YA, Wu WJ, Kung ML, Tai PH, Wu DC, Tai MH.

Oncogene. 2019 Sep;38(37):6461-6477. doi: 10.1038/s41388-019-0886-3. Epub 2019 Jul 22.

PMID:
31332288
5.

Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study.

Gangaraju R, Chen Y, Hageman L, Wu J, Francisco L, Battles K, Kung M, Ness E, Parman M, Weisdorf DJ, Forman SJ, Arora M, Armenian SH, Bhatia S.

Biol Blood Marrow Transplant. 2019 Nov;25(11):2261-2266. doi: 10.1016/j.bbmt.2019.06.032. Epub 2019 Jul 3.

PMID:
31278995
6.

Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).

Ho PW, Leung CT, Liu H, Pang SY, Lam CS, Xian J, Li L, Kung MH, Ramsden DB, Ho SL.

Autophagy. 2019 Apr 14:1-24. doi: 10.1080/15548627.2019.1603545. [Epub ahead of print]

PMID:
30983487
7.

Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study.

Gangaraju R, Chen Y, Hageman L, Wu J, Francisco L, Kung M, Ness E, Parman M, Weisdorf DJ, Forman SJ, Arora M, Armenian SH, Bhatia S.

Br J Haematol. 2019 Jul;186(2):367-370. doi: 10.1111/bjh.15866. Epub 2019 Mar 18. No abstract available.

PMID:
30883690
8.

Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling.

Huang CC, Cheng SH, Wu CH, Li WY, Wang JS, Kung ML, Chu TH, Huang ST, Feng CT, Huang SC, Tai MH.

Oncogene. 2019 Apr;38(17):3201-3215. doi: 10.1038/s41388-018-0658-5. Epub 2019 Jan 9.

PMID:
30626939
9.

Late Mortality after Allogeneic Bone Marrow Transplantation in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic Anemia.

Holmqvist AS, Chen Y, Wu J, Battles K, Francisco L, Hageman L, Kung M, Ness E, Parman M, Winther JF, Rosenthal J, Arora M, Armenian SH, Bhatia S.

Biol Blood Marrow Transplant. 2019 Apr;25(4):749-755. doi: 10.1016/j.bbmt.2018.12.063. Epub 2018 Dec 20.

PMID:
30578940
10.

Zingerone Nanotetramer Strengthened the Polypharmacological Efficacy of Zingerone on Human Hepatoma Cell Lines.

Kung ML, Lin PY, Huang ST, Tai MH, Hsieh SL, Wu CC, Yeh BW, Wu WJ, Hsieh S.

ACS Appl Mater Interfaces. 2019 Jan 9;11(1):137-150. doi: 10.1021/acsami.8b14559. Epub 2018 Dec 19.

PMID:
30566322
11.

Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study.

Rivera F, Benavides M, Gallego J, Guillen-Ponce C, Lopez-Martin J, Küng M.

Pancreatology. 2019 Jan;19(1):64-72. doi: 10.1016/j.pan.2018.10.004. Epub 2018 Oct 17.

12.

Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2).

Wadhwa A, Chen Y, Holmqvist A, Wu J, Ness E, Parman M, Kung M, Hageman L, Francisco L, Braunlin E, Miller W, Lund T, Armenian S, Arora M, Orchard P, Bhatia S.

Biol Blood Marrow Transplant. 2019 Feb;25(2):328-334. doi: 10.1016/j.bbmt.2018.09.035. Epub 2018 Oct 4.

PMID:
30292746
13.

Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.

Holmqvist AS, Chen Y, Wu J, Battles K, Bhatia R, Francisco L, Hageman L, Kung M, Ness E, Parman M, Salzman D, Wadhwa A, Winther JF, Rosenthal J, Forman SJ, Weisdorf DJ, Armenian SH, Arora M, Bhatia S.

JAMA Oncol. 2018 Dec 1;4(12):e182453. doi: 10.1001/jamaoncol.2018.2453. Epub 2018 Dec 13.

14.

Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2.

Holmqvist AS, Chen Y, Wu J, Kung M, Ness E, Parman M, Francisco L, Hageman L, Battles K, Bhatia R, Salzman D, Winther JF, Rosenthal J, Forman SJ, Weisdorf DJ, Armenian SH, Arora M, Bhatia S.

Leukemia. 2018 Dec;32(12):2706-2709. doi: 10.1038/s41375-018-0171-4. Epub 2018 Jun 26. No abstract available.

PMID:
29946190
15.

Correction to: Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch1/Akt/eNOS signaling in endothelial cells.

Huang CC, Kuo HM, Wu PC, Cheng SH, Chang TT, Chang YC, Kung ML, Wu DC, Chuang JH, Tai MH.

Angiogenesis. 2018 Nov;21(4):901. doi: 10.1007/s10456-018-9615-8.

PMID:
29748783
16.

Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report.

Holmqvist AS, Chen Y, Wu J, Battles K, Bhatia R, Francisco L, Hageman L, Kung M, Ness E, Parman M, Salzman D, Winther JF, Rosenthal J, Forman SJ, Weisdorf DJ, Arora M, Armenian SH, Bhatia S.

Blood. 2018 Jun 14;131(24):2720-2729. doi: 10.1182/blood-2018-02-831156. Epub 2018 Apr 16.

17.

Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch1/Akt/eNOS signaling in endothelial cells.

Huang CC, Kuo HM, Wu PC, Cheng SH, Chang TT, Chang YC, Kung ML, Wu DC, Chuang JH, Tai MH.

Angiogenesis. 2018 May;21(2):299-312. doi: 10.1007/s10456-018-9596-7. Epub 2018 Jan 30. Erratum in: Angiogenesis. 2018 May 10;:.

PMID:
29383634
18.

Functional engineered mesenchymal stem cells with fibronectin-gold composite coated catheters for vascular tissue regeneration.

Chen YW, Hsieh SC, Yang YC, Hsu SH, Kung ML, Lin PY, Hsieh HH, Lin CH, Tang CM, Hung HS.

Nanomedicine. 2018 Apr;14(3):699-711. doi: 10.1016/j.nano.2017.12.023. Epub 2018 Jan 8.

PMID:
29325741
19.

Erratum: Stable and solubilized active Au atom clusters for selective epoxidation of cis-cyclooctene with molecular oxygen.

Qian L, Wang Z, Beletskiy EV, Liu J, Dos Santos HJ, Li T, Rangel MDC, Kung MC, Kung HH.

Nat Commun. 2017 Aug 11;8:15669. doi: 10.1038/ncomms15669.

20.

Burden of rare variants in ALS genes influences survival in familial and sporadic ALS.

Pang SY, Hsu JS, Teo KC, Li Y, Kung MHW, Cheah KSE, Chan D, Cheung KMC, Li M, Sham PC, Ho SL.

Neurobiol Aging. 2017 Oct;58:238.e9-238.e15. doi: 10.1016/j.neurobiolaging.2017.06.007. Epub 2017 Jun 20.

21.

Selective serotonin reuptake inhibitor, fluoxetine, impairs E-cadherin-mediated cell adhesion and alters calcium homeostasis in pancreatic beta cells.

Chang HY, Chen SL, Shen MR, Kung ML, Chuang LM, Chen YW.

Sci Rep. 2017 Jun 14;7(1):3515. doi: 10.1038/s41598-017-03747-0.

22.

Silver decorated copper oxide (Ag@CuO) nanocomposite enhances ROS-mediated bacterial architecture collapse.

Kung ML, Tai MH, Lin PY, Wu DC, Wu WJ, Yeh BW, Hung HS, Kuo CH, Chen YW, Hsieh SL, Hsieh S.

Colloids Surf B Biointerfaces. 2017 Jul 1;155:399-407. doi: 10.1016/j.colsurfb.2017.04.041. Epub 2017 Apr 23.

PMID:
28460302
23.

Predicting workers' compensation claims and disciplinary actions using SecureFit®: Further support for integrative models of workplace safety.

O'Connell M, Delgado K, Lawrence A, Kung M, Tristan E.

J Safety Res. 2017 Jun;61:77-81. doi: 10.1016/j.jsr.2017.02.010. Epub 2017 Mar 3.

PMID:
28454873
24.

[18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease.

Weng CC, Huang SL, Chen ZA, Lin KJ, Hsiao IT, Yen TC, Kung MP, Wey SP, Hsu CH.

Ann Nucl Med. 2017 Aug;31(7):506-513. doi: 10.1007/s12149-017-1174-3. Epub 2017 Apr 27.

PMID:
28451991
25.

Dual-phase 18F-florbetapir positron emission tomography in patients with primary progressive aphasia, Alzheimer's disease, and healthy controls: A preliminary study.

Kuo HC, Hsiao IT, Hsieh CJ, Huang CY, Huang KL, Wai YY, Chuang WL, Kung MP, Chu YC, Yen TC, Lin KJ, Huang CC.

J Formos Med Assoc. 2017 Dec;116(12):964-972. doi: 10.1016/j.jfma.2017.03.003. Epub 2017 Apr 20.

26.

Stable and solubilized active Au atom clusters for selective epoxidation of cis-cyclooctene with molecular oxygen.

Qian L, Wang Z, Beletskiy EV, Liu J, Dos Santos HJ, Li T, Rangel MD, Kung MC, Kung HH.

Nat Commun. 2017 Mar 28;8:14881. doi: 10.1038/ncomms14881. Erratum in: Nat Commun. 2017 Aug 11;8:15669.

27.

Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.

Weng CC, Chen ZA, Chao KT, Ee TW, Lin KJ, Chan MH, Hsiao IT, Yen TC, Kung MP, Hsu CH, Wey SP.

PLoS One. 2017 Mar 3;12(3):e0173503. doi: 10.1371/journal.pone.0173503. eCollection 2017.

28.

Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.

Liu HF, Ho PW, Leung GC, Lam CS, Pang SY, Li L, Kung MH, Ramsden DB, Ho SL.

Sci Rep. 2017 Jan 18;7:40887. doi: 10.1038/srep40887.

29.

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.

Rochlitz C, Bigler M, von Moos R, Bernhard J, Matter-Walstra K, Wicki A, Zaman K, Anchisi S, Küng M, Na KJ, Bärtschi D, Borner M, Rordorf T, Rauch D, Müller A, Ruhstaller T, Vetter M, Trojan A, Hasler-Strub U, Cathomas R, Winterhalder R; Swiss Group for Clinical Cancer Research (SAKK).

BMC Cancer. 2016 Oct 10;16(1):780.

30.

Prominent Vascularization Capacity of Mesenchymal Stem Cells in Collagen-Gold Nanocomposites.

Hsieh SC, Chen HJ, Hsu SH, Yang YC, Tang CM, Chu MY, Lin PY, Fu RH, Kung ML, Chen YW, Yeh BW, Hung HS.

ACS Appl Mater Interfaces. 2016 Oct 26;8(42):28982-29000. doi: 10.1021/acsami.6b09330. Epub 2016 Oct 13.

PMID:
27714998
31.

Development of a screening tool to prioritize testing for the carcinogenic hazard of residual aromatic extracts and related petroleum streams.

Goyak KO, Kung MH, Chen M, Aldous KK, Freeman JJ.

Toxicol Lett. 2016 Dec 15;264:99-105. doi: 10.1016/j.toxlet.2016.10.001. Epub 2016 Oct 3.

PMID:
27713023
32.

Magnetite nanoparticle interactions with insulin amyloid fibrils.

Chen YW, Chang CW, Hung HS, Kung ML, Yeh BW, Hsieh S.

Nanotechnology. 2016 Oct 14;27(41):415702. doi: 10.1088/0957-4484/27/41/415702. Epub 2016 Sep 2.

PMID:
27585675
33.

Supported Tetrahedral Oxo-Sn Catalyst: Single Site, Two Modes of Catalysis.

Beletskiy EV, Hou X, Shen Z, Gallagher JR, Miller JT, Wu Y, Li T, Kung MC, Kung HH.

J Am Chem Soc. 2016 Apr 6;138(13):4294-7. doi: 10.1021/jacs.5b13436. Epub 2016 Mar 25.

PMID:
26986621
34.

Nanoscale characterization illustrates the cisplatin-mediated biomechanical changes of B16-F10 melanoma cells.

Kung ML, Hsieh CW, Tai MH, Weng CH, Wu DC, Wu WJ, Yeh BW, Hsieh SL, Kuo CH, Hung HS, Hsieh S.

Phys Chem Chem Phys. 2016 Mar 14;18(10):7124-31. doi: 10.1039/c5cp07971c.

PMID:
26886764
35.

Outcomes of Limb-Sparing Surgery Using Two Generations of Metal Endoprosthesis in 45 Dogs With Distal Radial Osteosarcoma. A Veterinary Society of Surgical Oncology Retrospective Study.

Mitchell KE, Boston SE, Kung M, Dry S, Straw RC, Ehrhart NP, Ryan SD.

Vet Surg. 2016 Jan;45(1):36-43. doi: 10.1111/vsu.12423.

PMID:
26731595
36.

Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.

Chen SC, Hu TH, Huang CC, Kung ML, Chu TH, Yi LN, Huang ST, Chan HH, Chuang JH, Liu LF, Wu HC, Wu DC, Chang MC, Tai MH.

Oncotarget. 2015 Jun 30;6(18):16253-70.

37.

A functional study of proximal goat β-casein promoter and intron 1 in immortalized goat mammary epithelial cells.

Kung MH, Lee YJ, Hsu JT, Huang MC, Ju YT.

J Dairy Sci. 2015 Jun;98(6):3859-75. doi: 10.3168/jds.2014-9054. Epub 2015 Apr 1.

38.

PMCA4 (ATP2B4) mutation in familial spastic paraplegia causes delay in intracellular calcium extrusion.

Ho PW, Pang SY, Li M, Tse ZH, Kung MH, Sham PC, Ho SL.

Brain Behav. 2015 Apr;5(4):e00321. doi: 10.1002/brb3.321. Epub 2015 Feb 16.

39.

Enhanced reactive oxygen species overexpression by CuO nanoparticles in poorly differentiated hepatocellular carcinoma cells.

Kung ML, Hsieh SL, Wu CC, Chu TH, Lin YC, Yeh BW, Hsieh S.

Nanoscale. 2015 Feb 7;7(5):1820-9. doi: 10.1039/c4nr05843g.

PMID:
25521936
40.

Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma.

Kung MBJ, Poirier VJ, Dennis MM, Vail DM, Straw RC.

Vet Comp Oncol. 2016 Dec;14(4):e135-e145. doi: 10.1111/vco.12121. Epub 2014 Nov 13.

PMID:
25393921
41.

Tetrahedral Sn-silsesquioxane: synthesis, characterization and catalysis.

Beletskiy EV, Shen Z, Riofski MV, Hou X, Gallagher JR, Miller JT, Wu Y, Kung HH, Kung MC.

Chem Commun (Camb). 2014 Dec 25;50(99):15699-701. doi: 10.1039/c4cc07897g. Epub 2014 Oct 31.

PMID:
25360661
42.

LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity.

Liu HF, Lu S, Ho PW, Tse HM, Pang SY, Kung MH, Ho JW, Ramsden DB, Zhou ZJ, Ho SL.

Ann Clin Transl Neurol. 2014 Mar;1(3):199-208. doi: 10.1002/acn3.45. Epub 2014 Mar 4.

43.

Eco-friendly synthesis of shrimp egg-derived carbon dots for fluorescent bioimaging.

Lin PY, Hsieh CW, Kung ML, Chu LY, Huang HJ, Chen HT, Wu DC, Kuo CH, Hsieh SL, Hsieh S.

J Biotechnol. 2014 Nov 10;189:114-9. doi: 10.1016/j.jbiotec.2014.08.043. Epub 2014 Sep 16.

PMID:
25225122
44.

Do retrieval analysis and blood metal measurements contribute to our understanding of adverse local tissue reactions?

Campbell PA, Kung MS, Hsu AR, Jacobs JJ.

Clin Orthop Relat Res. 2014 Dec;472(12):3718-27. doi: 10.1007/s11999-014-3893-2. Review.

45.

PMCA4 (ATP2B4) mutation in familial spastic paraplegia.

Li M, Ho PW, Pang SY, Tse ZH, Kung MH, Sham PC, Ho SL.

PLoS One. 2014 Aug 13;9(8):e104790. doi: 10.1371/journal.pone.0104790. eCollection 2014.

46.

Free-standing nitrogen-doped graphene paper as electrodes for high-performance lithium/dissolved polysulfide batteries.

Han K, Shen J, Hao S, Ye H, Wolverton C, Kung MC, Kung HH.

ChemSusChem. 2014 Sep;7(9):2545-53. doi: 10.1002/cssc.201402329. Epub 2014 Jul 22.

PMID:
25049064
47.

Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.

Hsiao IT, Weng YH, Hsieh CJ, Lin WY, Wey SP, Kung MP, Yen TC, Lu CS, Lin KJ.

JAMA Neurol. 2014 Jun;71(6):758-66. doi: 10.1001/jamaneurol.2014.290. Erratum in: JAMA Neurol. 2014 Jun;71(6):803.

PMID:
24756323
48.

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

Chu TH, Chan HH, Kuo HM, Liu LF, Hu TH, Sun CK, Kung ML, Lin SW, Wang EM, Ma YL, Cheng KH, Lai KH, Wen ZH, Hsu PI, Tai MH.

Oncotarget. 2014 Mar 30;5(6):1475-90.

49.

Generating and stabilizing Co(I) in a nanocage environment.

Shen J, Kung MC, Shen Z, Wang Z, Gunderson WA, Hoffman BM, Kung HH.

J Am Chem Soc. 2014 Apr 9;136(14):5185-8. doi: 10.1021/ja412446y. Epub 2014 Mar 31.

50.

Predictors of venous thromboembolic events associated with central venous port insertion in cancer patients.

Hohl Moinat C, Périard D, Grueber A, Hayoz D, Magnin JL, André P, Kung M, Betticher DC.

J Oncol. 2014;2014:743181. doi: 10.1155/2014/743181. Epub 2014 Feb 9.

Supplemental Content

Support Center